**Specification Table**TableSubject area*Biology*More specific subject area*Bioinformatics and cell signaling*Type of data*Transcriptome, table, figure*How data was acquired*High-throughput RNA sequencing using Illumina HiSeq 2500*Data format*Raw, fastq files*Experimental factors*RNA isolation, cDNA library construction and sequencing*Experimental features*Transcriptome analysis of Cos1 cells depleted of SHOC2 using:Cos1 cells expressing non-targeting shRNA (Cos-NT) (control; n=3);Cos1 cells expressing SHOC2 specific shRNA (Cos-LV1) (n=3)*Data source location*Lexington, KY, USA*Data accessibility*The data is available with this article and via NCBI׳s GEO through the direct link*<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSSE67063>*. GEO: GSE67063*

**Value of the data**•While the activation of RAF, MEK, and ERK kinases in the ERK1/2 signaling pathway have been studied extensively, little is known about the activity of the ERK1/2 pathway in context of specific scaffolding modules. This dataset provides a novel look into the transcriptional response mediated through the SHOC2/ERK1/2 signaling axis, which can give greater insight into the mechanisms regulating signals of the ERK1/2 pathway [@bib1].•SHOC2 depletion appears to attenuate cell motility and adhesion which can be further analyzed with this data.•Since SHOC2 is involved in the process of positively regulating RAS protein signal transduction, this dataset can be further examined to study downstream targets of RAS.•As of 2/25/2016, only six series (including this dataset) exist in GEO with transcriptional profiles of the Cos1 cell line. This dataset becomes only the third high throughput sequencing transcriptional profile for Cos1, yielding to the potential for generalized transcriptome studies of the Cos1 cell line.

1. Data {#s0005}
=======

This data consists of six high-throughput sequencing samples of Shoc2 depleted (*n*=3) or not depleted (*n*=3) Cos1 cells generated from an Illumina HiSeq 2000. Data is available in the Gene Expression Omnibus (GEO) [@bib2], [@bib3] accession GEO: GSE637063 through the direct link <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE67063> as well as through NCBI׳s Sequence Read Archive [@bib4] through the direct link <http://www.ncbi.nlm.nih.gov/sra?term=SRP056324>.

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Experimental design {#s0015}
------------------------

All procedures were performed in accordance with published NIH Guidelines and the University of Kentucky Institutional Biosafety requirements. This data was designed to measure the transcriptional effects of the depletion of the SHOC2 protein within Cos1 cell lines. Control and treated cells were prepared as detailed in [Section 2.2](#s0020){ref-type="sec"}. A total of six samples were examined, with three control replicates, and three SHOC2-depleted replicates ([Table 1](#t0005){ref-type="table"}).

2.2. Sample preparation {#s0020}
-----------------------

Cos1 kidney cells (American Type Culture Collection (ATCC), Manassas, VA) derived from the African green monkey (*Cercopithecidae Chlorocebus sp.)* were transduced with lentiviruses that carry non-targeting shRNA (NT) or lentiviruses carrying the shRNA targeting SHOC2 (LV1). The stable cells (Cos-NT and Cos-LV1) were grown in Dulbecco׳s Modified Eagle Medium (DMEM) with 10% Fetal Bovine Serum (FBS) supplemented with sodium pyruvate, MEM-NEAA, penicillin, streptomycin, and L-glutamate (Thermo Fisher Scientific, Waltham, MA) at 37 °C, 5% CO~2~. Cells were serum-starved for 14 h, and then treated with 0.2 ng/ml of epidermal growth factor (EGF) (BD Biosciences, San Jose, CA) for 90 min. Total RNA was extracted using Bio-Rad PureZOL/Aurum total RNA isolation kits (Bio-Rad, Hercules, CA) according to the manufacturer׳s instructions. The RNA quality was examined using an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). RNA-Seq libraries were constructed in the University of Texas Southwestern Genomics Core using Illumina׳s mRNA-Seq sample preparation kits (Illumina Inc., San Diego, CA) for poly-A enrichment in order to generate full mRNA sequence from any poly-A tailed RNA. The process for poly-A enrichment involved extraction of mRNA using oligo (dT) magnetic beads followed by shearing into short fragments approximately 200 bases in length. The UT Southwestern Genomics Core was responsible for mRNA isolation, cDNA synthesis, fragmentation, adaptor ligation, size selection, amplification, and quality control (QC) of the prepared libraries.

2.3. Data acquisition {#s0025}
---------------------

Sequencing was performed at the University of Texas Southwestern Medical Center׳s Genomics Core using an Illumina HiSeq 2500 instrument resulting in 50 bp single end reads for each sample. Six raw sequencing files representing two conditions (control: NT and treatment: LV1) were obtained from the Illumina HiSeq 2500 instrument using the Illumina Casava basecalling software. Quality control (QC) of the raw sequence data was performed using FastQC (version 0.10.1) [@bib5]. Based upon the QC results, minor sequence trimming was performed using Trimmomatic (version 0.27) [@bib6] with a sliding window, trimming once the average quality within a 3-base window falls below a quality score of 20. Following trimming, QC was once again tested against the trimmed sequences. The trimmed sequences were determined to pass the QC step.

Trimmed reads were aligned to the vervet (green) monkey reference genome (*Chlorocebus sabaeus*) ChiSab1.0 (GenBank [@bib7] accession GCA_000409795.1) downloaded from the Ensembl pre-release site (<http://pre.ensembl.org/Chlorocebus_sabaeus/Info/Index>) using Tophat2 v2.0.10 [@bib8] with the multithreading option -p 4 and the remaining parameters as the default allowing for two mismatches. Tophat2 was using bowtie2 v2.1.0.0 [@bib9] as the underlying mapper. A gene transfer format (GTF) file for the vervet monkey downloaded from the Ensembl ftp site ([ftp://ftp.ensembl.org/pub/pre/gtf/chlorocebus_sabaeus/](http://ftp://ftp.ensembl.org/pub/pre/gtf/chlorocebus_sabaeus/){#ir0025}) was used as a guide for intron/exon splice junction mapping. The GTF file Chlorocebus.sabaeus.Chlsabe.0.pre.gtf was modified slightly to include "chr" within the chromosome label. Note the final GTF file contains separate genes according to whether they are annotated according to human protein homologs or *C. sabaeus* EST sequences.

Aligned RNA-seq reads were assembled onto the GTF annotation file using cufflinks (version 2.1.1) [@bib10], resulting in a total of 51,520 genes. For each comparison, both cufflinks assemblies were merged using cuffmerge [@bib10] and the resulting merged GTF file serves as the transcript input for differential gene expression. The number of aligned reads ranges from 82.7% to 84.3% of the original reads, indicating a high success rate ([Table 2](#t0010){ref-type="table"}).

Differentially expressed genes were identified by comparing the combined alignments of samples 4, 5 and 6 (LV1) to the combined alignments of samples 1, 2 and 3 (NT) using cuffdiff2 (version 2.1.1) [@bib11] with the multithreading option -p 8 and the minimum alignment count of 7 (\--min-alignment-count 7) to determine gene expression levels in Fragments Per Kilobase of transcript per Megabase (FPKM) and differential expression between the two conditions. All other parameters were set to the defaults. A false-discovery rate (FDR) corrected *q*-value cutoff of 0.05 was used to determine differentially expressed genes. A list of commands used in the RNASeq pipeline is given in [Table 3](#t0015){ref-type="table"}.

For each human gene, the corresponding Ensembl Protein ID, Gene Name, and EntrezGene ID were identified from BioMart [@bib12] in Ensembl [@bib13] (Ensembl Genes v77; Homo sapiens genes GrCh38). This resulting dataset was further filtered to obtain a total of 113,308 entries having values for all three fields. This data file was then used to obtain homologs to the resulting *C. sabaeus* dataset.

The resulting cuffdiff gene_exp.diff file results in 27,265 transcript identifiers from 23,709 unique regions. Note that most of the genes removed from the cufflinks portion to cuffdiff are short EST sequences. This file was parsed for differentially expressed genes defined by a *q*-value cutoff of 0.05. A total of 3907 of the genes were determined to be differentially expressed. Adding a fold-change cutoff of ±1.2 reduces this to 1987 DEGs, and a fold-change cutoff of ±1.5 reduces the list to 879 DEGs. Most of these had a human Ensembl protein homolog (3143) while some were only identified by *C. sabaeus* ESTs (764) ([Table 4](#t0020){ref-type="table"}). A list of the top 20 differentially expressed genes is shown in [Table 5](#t0025){ref-type="table"}.

2.4. Transcription factor analysis {#s0030}
----------------------------------

Those genes with a human Ensembl protein homolog were further examined to identify transcription factors by cross-referencing Transfac [@bib14] and TcoF-DB [@bib15] databases. Transfac consists of 2301 human transcription factors. Of these, 57 are downregulated in this data set ([Table 6](#t0030){ref-type="table"}) while 60 are upregulated ([Table 7](#t0035){ref-type="table"}). TcoF-DB consists of transcription co-factors. The list of transcription factors and transcription co-factors were downloaded from TcoF dated 20100927. TcoF lists a total of 1365 transcription factors and 529 transcription cofactors. A total of 54 transcription co-factors were found to be differentially expressed, with 22 down-regulated ([Table 8](#t0040){ref-type="table"}) and 32 up-regulated ([Table 9](#t0045){ref-type="table"}).

2.5. Categorical enrichment {#s0035}
---------------------------

Human Entrez gene identifiers for protein homologs were used as input into categoryCompare [@bib16] for analysis of enriched annotations including Gene Ontology [@bib17] Biological Process (GO:BP), Molecular Function (GO:MF) and KEGG Pathways [@bib18]. A total of 169 GO:BPs were enriched by down-regulated genes, and 188 GO:BPs were enriched by up-regulated genes. Enriched GO:MFs included 26 enriched by down-regulation, and 21 by up-regulation. In terms of KEGG Pathways, 0 were enriched for by down-regulated genes, and four were enriched by up-regulated genes. The graphical results of categoryCompare are shown in [Supplementary Fig. 1](#s0045){ref-type="fn"} (GO:BP) and [Supplementary Fig. 2](#s0045){ref-type="fn"} (GO:MF). Additional categorical enrichment analysis was performed by Panther [@bib19] for GO:MF ([Table 10](#t0050){ref-type="table"}), Gene Ontology Cellular Component (GO:CC) ([Table 11](#t0055){ref-type="table"}), Panther Protein classes ([Table 12](#t0060){ref-type="table"}), and Gene Ontology Biological Process (GO:BP) ([Table 13](#t0065){ref-type="table"}). The Panther GO:MF results indicate an overall enrichment in binding and catalytic activity while the top four enriched GO:CC are cell part, organelle, membrane, and extracellular region.

Appendix A. Supplementary material {#s0050}
==================================

Supplementary materialGO:BP enrichments for differentially expressed genes, as determined by categoryCompare.GO:MF enrichments for differentially expressed genes, as determined by categoryCompare.
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###### 

Sample information.

Table 1

  Sample number   Sample name   Sample description            GEO sample ID
  --------------- ------------- ----------------------------- ---------------
  1               Cos-NT1       Non-targeting, replicate 1    GSM1637966
  2               Cos-NT2       Non-targeting, replicate 2    GSM1637967
  3               Cos-NT3       Non-targeting, replicate 3    GSM1637968
  4               Cos-LV1       SHOC2-depleted, replicate 1   GSM1637969
  5               Cos-LV2       SHOC2-depleted, replicate 2   GSM1637970
  6               Cos-LV3       SHOC2-depleted, replicate 3   GSM1637971

###### 

Read trimming and alignment information.

Table 2

  Sample name   Raw reads    Raw bases       Reads after trimming   Bases after trimming   Aligned reads   \% Raw reads aligned (%)
  ------------- ------------ --------------- ---------------------- ---------------------- --------------- --------------------------
  Cos-NT1       42,952,132   2,154,871,134   38,607,172             1,501,729,353          36,207,885      84.3
  Cos-NT2       38,735,131   1,942,967,564   34,782,083             1,355,688,866          32,331,306      83.5
  Cos-NT3       44,044,083   2,209,603,724   39,381,284             1,528,332,458          36,772,731      83.5
  Cos-LV1       43,474,834   2,180,981,048   39,011,336             1,518,169,588          36,519,959      84.0
  Cos-LV2       48,201,304   2,417,879,938   43,104,467             1,675,700,194          39,878,182      82.7
  Cos-LV3       40,265,842   2,019,730,082   35,969,848             1,396,805,479          33,394,305      82.9

###### 

RNA-Seq pipeline commands.

Table 3

  Task                                                           Command
  -------------------------------------------------------------- ------------------------------------------------------------------------------------
  QA/QC                                                          fastqc \<fastqFN\> -o \<FASTQC_DIRECTORY\>
  Trimming                                                       java --classpath Trimmomatic-0.27.far TrimmomaticSE /
  --phred33 \<fastqIN_FN\> \<fastqOUT_FN\> SLIDINGWINDOW:3:20    
  Alignment                                                      tophat2 -p 4 -o \<outputdir\> -G genes.gtf /
  \--no-coverage-search ChSa \<trimmed_fastq_file\>              
  Transcript detection                                           cufflinks -p 4 -o \<CUFF_OUT_FN\> -G genes.gtf \<CONDITION_DIR\>/accepted_hits.bam
  Transcript merging                                             cuffmerge --o cuffmerg_out --s cs1.fa samples.gtf.txt
  Differential expression                                        cuffdiff -o cuffdiff_out -p 8 \--min-alignment-count 7/
  -u cuffmerg_out_gtf/merged.gtf /                               
  Cos-NT.1_1.fastq.trim.tophat2.newFasta/accepted_hits.bam,/     
  Cos-NT\#2_1.fastq.trim.NewFasta.tophat2/accepted_hits.bam,/    
  Cos-NT.3_1.fastq.trim.tophat2.newFasta/accepted_hits.bam/      
  Cos-LV1\#4_1.fastq.trim.NewFasta.tophat2/accepted_hits.bam,/   
  Cos-LV1.5_1.fastq.trim.tophat2.newFasta/accepted_hits.bam,/    
  Cos-LV1.6_1.fastq.trim.tophat2.newFasta/accepted_hits.bam      

###### 

Differentially expressed genes (DEGs) as determined by cuffdiff, NT (control) vs. LV1 (SHOC2 depleted) (*q*-value ≤ 0.05).

Table 4

  Method                  Up-regulated   Down-regulated   Total
  ----------------------- -------------- ---------------- -------
  Genes with Ensembl ID   1443           1700             3143
  Unique Ensembl IDs      1367           1678             3045
  *C. sabaeus* ESTs       386            378              764

###### 

Top 20 differentially expressed genes (out of 853) (fold change \>1.5, FDR \<0.05).

Table 5

  **Symbol**     **Log**^**2**^**CPM**   **FPKM**   **Log ratio**   ***p*-Value**   **FDR**
  -------------- ----------------------- ---------- --------------- --------------- -----------
  **AMOT**       10.37994                11758      0.683           7.23E−61        3.08E−58
  **GLA**        8.609800                5982       −1.307          5.02E−153       6.15E−150
  **LGALS3BP**   8.017922                4571       −1.613          8.44E−184       4.13E−180
  **MYC**        7.994633                4089       −1.234          1.21E−153       1.69E−150
  **NCAPG2**     8.166777                2593       0.590           1.78E−47        4.59E−45
  **NEFM**       7.523503                2574       −0.683          3.22E−54        1.21E−51
  **NDRG1**      7.313191                2566       −1.487          6.95E−179       2.27E−175
  **SLIT2**      8.260966                2254       1.096           4.64E−171       1.14E−167
  **SLC39A10**   7.265485                2199       −1.038          2.58E−31        2.87E−29
  **MLLT4**      7.894645                2118       0.591           1.82E−33        2.35E−31
  **NPTX1**      7.196138                2049       −0.807          1.50E−35        2.20E−33
  **KRT8**       5.567323                1816       −0.880          6.29E−51        1.99E−48
  **TRIB1**      6.685121                1736       −1.387          8.78E−162       1.43E−158
  **TMEM164**    6.816386                1661       −0.813          1.84E−63        9.46E−61
  **SORD**       6.845924                1637       −0.759          2.26E-49        6.71E−47
  **CLU**        6.777606                1627       −0.779          1.41E−47        3.73E−45
  **ADCY3**      6.811043                1562       −0.720          2.13E−40        4.08E−38
  **CXCR4**      6.573526                1514       −1.437          1.12E−109       1.10E−106
  **ALDH1A2**    6.423321                1487       −2.044          1.57E−238       1.54E−234
  **TLE4**       7.369268                1437       0.714           1.21E−55        4.75E−53

###### 

Down-regulated genes (*n*=57) cross-listed as transcription factors in Transfac.

Table 6

  -------- --------- -------- -------- -------- --------
  AHCTF1   GTF2A1L   MAF      NFIX     SALL4    TFEB
  AR       GTF2E2    MAFA     NKX1-2   SOX5     TP53
  CAV1     GTF2F2    MAMSTR   NKX6-1   SP1      TRIM21
  CDH1     HES5      MEF2C    NR2F2    SP4      UBE3A
  DACH2    HES7      MITF     OLIG2    SREBF1   XBP1
  E2F4     HIVEP3    MLX      OVOL2    STAT5B   ZBTB7B
  E2F5     JUNB      MYB      PITX3    TBX1     ZNF143
  ELF4     KLF6      MYC      POU3F2   TCEAL3   
  FOXN2    KLF9      MYPOP    POU3F3   TCF24    
  GHR      LSR       NFATC2   PRR5     TFB2M    
  -------- --------- -------- -------- -------- --------

###### 

Up-regulated genes (*n*=60) cross-listed as transcription factors in Transfac.

Table 7

  -------- ------- --------- -------- --------- ---------
  ACE2     DMRT3   FOXP2     LBX1     PBRM1     TCEANC2
  ATF5     EBF2    GTF2A1    LMX1B    PBXIP1    TCF7L2
  BARD1    ELP2    GTF2H5    LZTFL1   PIR       TFAP2A
  BCLAF1   EPAS1   GTF2I     MTF1     POU2F1    TP73
  CDX2     ETV3    GTF3C3    NFAT5    PPARD     TRRAP
  CNOT4    FHL1    HINFP     NFKBIZ   PRDM16    TWIST2
  CNOT6    FLI1    IFI16     NFYA     SALL2     VIM
  CREBBP   FOXC1   ISL1      NFYC     SPEN      XRCC4
  CTBP1    FOXF2   KLF12     NR2F1    SUPT16H   YAP1
  DACH1    FOXO4   L3MBTL1   NR6A1    TAX1BP3   ZEB1
  -------- ------- --------- -------- --------- ---------

###### 

Down-regulated genes (*n*=22) cross-listed as transcription co-factors in TcoF.

Table 8

  ------- ------- ------- ------- ------- -------
  AGO2    EYA2    HMGA2   NAB2    SAP30   THAP1
  BCL3    FHL2    MAML3   NUP62   SIAH2   TRIB3
  EID2    HDAC8   MBD2    PTRF    SSBP2   
  ERBB4   HDAC9   MTA3    NAB2    TGFB1   
  ------- ------- ------- ------- ------- -------

###### 

Up-regulated genes (*n*=32) cross-listed as transcription co-factors in TcoF.

Table 9

  ------ ------- ------- ------- ------- ------- -------
  ATN1   CRY1    HIPK2   PEX14   POGZ    SSBP3   TXNIP
  BRD8   CTBP1   KDM5A   PHF1    RING1   STK36   YAP1
  CBX8   ELP2    MED20   PIR     SMAD6   TAF9B   
  CHD4   ERCC6   MED21   PNRC1   SMAD7   TLE4    
  CHD8   HCFC1   NSD1    PNRC2   SNIP1   TRRAP   
  ------ ------- ------- ------- ------- ------- -------

###### 

Gene Ontology Molecular Function (GO:MF) enriched categories determined by Panther.

Table 10

  **GO Molecular Function**                                         **\# of genes**   **Percentage (%)**
  ----------------------------------------------------------------- ----------------- --------------------
  Binding (GO:0005488)                                              272               32.60
  Catalytic activity (GO:0003824)                                   211               25.30
  Nucleic acid binding transcription factor activity (GO:0001071)   102               12.20
  Receptor activity (GO:0004872)                                    89                10.70
  Transporter activity (GO:0005215)                                 62                7.40
  Structural molecule activity (GO:0005198)                         45                5.40
  Enzyme regulator activity (GO:0030234)                            42                5.00
  Protein binding transcription factor activity (GO:0000988)        8                 1.00
  Translation regulator activity (GO:0045182)                       1                 0.10
  Channel regulator activity (GO:0016247)                           1                 0.10
  Antioxidant activity (GO:0016209)                                 1                 0.10

###### 

Gene Ontology Cellular Component (GO:CC) enriched categories determined by Panther.

Table 11

  **GO Cellular Component**             **\# of genes**   **Percentage (%)**
  ------------------------------------- ----------------- --------------------
  Cell part (GO:0044464)                130               36.00
  Organelle (GO:0043226)                74                20.50
  Membrane (GO:0016020)                 53                14.70
  Extracellular region (GO:0005576)     48                13.30
  Extracellular matrix (GO:0031012)     26                7.20
  Macromolecular complex (GO:0032991)   22                6.10
  Synapse (GO:0045202)                  4                 1.10
  Cell junction (GO:0030054)            4                 1.10

###### 

Panther Protein Class enriched categories.

Table 12

  **Panther Protein Class**                                     **\# of Genes**   **Percentage (%)**
  ------------------------------------------------------------- ----------------- --------------------
  Nucleic acid binding (PC00171)                                102               11.30
  Transcription factor (PC00218)                                98                10.80
  Receptor (PC00197)                                            92                10.20
  Hydrolase (PC00121)                                           72                7.90
  Transferase (PC00220)                                         67                7.40
  Signaling molecule (PC00207)                                  63                7.00
  Transporter (PC00227)                                         53                5.80
  Enzyme modulator (PC00095)                                    53                5.80
  Cytoskeletal protein (PC00085)                                34                3.80
  Oxidoreductase (PC00176)                                      34                3.80
  Kinase (PC00137)                                              29                3.20
  Protease (PC00190)                                            28                3.10
  Extracellular matrix protein (PC00102)                        27                3.00
  Cell adhesion molecule (PC00069)                              22                2.40
  Defense/immunity protein (PC00090)                            19                2.10
  Transfer/carrier protein (PC00219)                            18                2.00
  Membrane traffic protein (PC00150)                            18                2.00
  Calcium-binding protein (PC00060)                             17                1.90
  Phosphatase (PC00181)                                         11                1.20
  Ligase (PC00142)                                              10                1.10
  Structural protein (PC00211)                                  10                1.10
  Cell junction protein (PC00070)                               8                 0.90
  Transmembrane receptor regulatory/adaptor protein (PC00226)   6                 0.70
  Lyase (PC00144)                                               6                 0.70
  Surfactant (PC00212)                                          4                 0.40
  Chaperone (PC00072)                                           3                 0.30
  Storage protein (PC00210)                                     1                 0.10
  Isomerase (PC00135)                                           1                 0.10

###### 

Gene Ontology Biological Process (GO:BP) enriched categories determined by Panther.

Table 13

  **Panther Biological Process**                               **\# of genes**   **Percentage (%)**
  ------------------------------------------------------------ ----------------- --------------------
  Metabolic process (GO:0008152)                               351               22.00
  Cellular process (GO:0009987)                                324               20.30
  Biological regulation (GO:0065007)                           210               13.10
  Developmental process (GO:0032502)                           166               10.40
  Localization (GO:0051179)                                    125               7.80
  Multicellular organismal process (GO:0032501)                109               6.80
  Response to stimulus (GO:0050896)                            93                5.80
  Immune system process (GO:0002376)                           75                4.70
  Cellular component organization or biogenesis (GO:0071840)   49                3.10
  Biological adhesion (GO:0022610)                             38                2.40
  Apoptotic process (GO:0006915)                               30                1.90
  Reproduction (GO:0000003)                                    23                1.40
  Locomotion (GO:0040011)                                      5                 0.30
  Growth (GO:0040007)                                          1                 0.10
